Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corifollitropin alpha vs HMG for Ovarian Stimulation in IVF
NCT04416607Completed
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- Jun 2018
- Primary completion
- Jan 2019
- Modality
- rProtein (Recombinant Protein), Hormone, Biologic
- Countries
- 1
01
Overview
Open-label trial of corifollitropin alfa in female infertility (2 arms), sponsored by Hospital de Clínicas de Porto Alegre. Primary endpoint: Follicular Output Rate at 15 days. Started Jun 2018; status: completed.
02
Drugs
corifollitropin alfa
03
Conditions
female infertility
Beyond the preview
Go deeper on NCT04416607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04416607.